Reduction in mitochondrial membrane peroxidizability index…
623
Table 4.-‐
Fatty acyl composition (mol %) of total lipids of the heart mitochondria from control and
atenolol treated Wistar rats.
CONTROL
ATENOLOL
14:0
1.29±0.05
1.23±0.05
16:0
24.77±0.77
24.61±0.70
16:1n-‐7
1.14±0.05
1.18±0.04
18:0
25.45±0.22
24.28±0.22**
18:1n-‐9
14.29±0.31
14.65±0.24
18:2n-‐6
10.89±0.55
15.51±0.65***
18:3n-‐3
0.39±0.01
0.41±0.03
18:4n-‐3
0.13±0.01
0.13±0.01
20:0
0.18±0.01
0.18±0.01
20:1n-‐9
0.28±0.05
0.23±0.03
20:2n-‐6
0.93±0.03
1.01±0.03
20:3n-‐6
0.76±0.02
0.84±0.03
20:4n-‐6
11.61±0.48
10.16±0.26*
20:5n-‐3
0.14±0.01
0.15±0.01
22:0
0.24±0.02
0.19±0.01**
22:4n-‐6
0.34±0.03
0.23±0.02**
22:5n-‐6
0.35±0.03
0.20±0.01***
22:5n-‐3
1.04±0.05
0.88±0.04*
22:6n-‐3
5.52±0.43
3.69±0.15***
24:0
0.24±0.01
0.20±0.01**
ACL
18.02±0.04
17.90±0.02*
SFA
52.17±0.97
50.69±0.89
UFA
47.82±0.97
49.30±0.89
MUFA
15.71±0.37
16.06±0.29
PUFA
32.11±1.24
33.24±0.76
Values are means ± SEM from 8 different samples. ACL, acyl chain length, SFA, saturated fatty acids,
UFA unsaturated fatty acids, MUFA, monounsaturated fatty acids, PUFA polyunsaturated fatty acids.
Asterisks represent significant differences between the control and the atenolol group. * P<0.05, **
P<0.01, *** P<0.001.
